Data analytics service provider FactSet Research Systems Inc. (NYSE: FDS) reported higher revenues and adjusted earnings for the fourth quarter of fiscal 2025.
- Fourth-quarter revenue increased 6.2% year-over-year to $596.9 million; Organic ASV (Annual Subscription Value) was $2.37 billion at August 31, 2025, up 5.7% YoY
- Organic revenues grew 4.5% year over year to $587.3 million in the final three months of fiscal 2025
- Earnings per share, on a reported basis, were $4.03 in the fourth quarter, up 73.7% from the prior year
- On an adjusted basis, fourth-quarter earnings increased 8.3% year-over-year to $4.05 per share
- Operating margin was 29.7% in the August quarter, up around 700 bps YoY; adjusted operating margin dropped 200 bps annually to 33.8%
- For fiscal 2026, the management expects revenues to be in the range of $2.423 billion to $2.448 billion; the AVS growth forecast is 4%-6% for the year
- Net cash provided by operating activities was $212.1 million in the fourth quarter, an increase of 30% from last year
- Q4 free cash flow increased to $178.1 million from $137.2 million in the comparable period a year earlier
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
